Biogen Inc. insider trading
In the last twelve months insiders at Biogen Inc. filed 4 open-market sales worth $905,414 and 1 open-market purchase worth $585, on Form 4 with the SEC. The latest: Minor Lloyd, Director, sold 593 shares at $200.96 on 4 August 2026, filed 5 August 2026.
| Traded | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 4 August 2026 | Minor Lloyd | Director | Sale | 593 | $200.96 | $119,169 | Form 4 |
| 3 August 2026 | Minor Lloyd | Director | Sale | 593 | $203.34 | $120,581 | Form 4 |
| 12 February 2026 | Murphy Nicole | Head of Pharm Ops and Tech | Purchase | 3 | $195.03 | $585 | Form 4 |
| 9 February 2026 | Singhal Priya | Head of Development | Sale | 2,660 | $199.83 | $531,548 | Form 4 |
| 2 February 2026 | Singhal Priya | Head of Development | Sale | 748 | $179.30 | $134,116 | Form 4 |
Open-market purchases (code P) and sales (code S) only. Option exercises, grants, tax withholding and gifts are not shown. A filing with several lines appears once per line.
Source
Form 4 filings on EDGAR for Biogen Inc.: the company's filing index.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.